Literature DB >> 21566507

CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance.

Nilufar Pashaee1, Rachida Bouamar, Dennis A Hesselink, Joke I Roodnat, Ron H N van Schaik, Willem Weimar, Teun van Gelder.   

Abstract

BACKGROUND: The risk of long-term chronic allograft nephropathy and graft loss after kidney transplantation is increased in patients with a high intrapatient variability of tacrolimus (Tac) clearance.
METHODS: To test whether this intrapatient variability is associated with an individual's CYP3A5 genotype, we measured the intrapatient variability in Tac clearance in a cohort of 208 kidney transplant recipients treated with Tac and mycophenolate mofetil.
RESULTS: Tac dose requirement was significantly higher in patients expressing CYP3A5. However, intraindividual variability of Tac clearance was not related to CYP3A5 genotype.
CONCLUSIONS: Intraindividual variability in Tac clearance is not related to CYP3A5 genotype. Other factors, including patient adherence, may explain the variability in Tac clearance within an individual patient over time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566507     DOI: 10.1097/FTD.0b013e31821a7aa3

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  9 in total

1.  Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.

Authors:  Takenori Niioka; Hideaki Kagaya; Mitsuru Saito; Takamitsu Inoue; Kazuyuki Numakura; Ryohei Yamamoto; Tomonori Habuchi; Shigeru Satoh; Masatomo Miura
Journal:  Clin Exp Nephrol       Date:  2017-03-07       Impact factor: 2.801

2.  Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.

Authors:  Stephan R Seibert; David P Schladt; Baolin Wu; Weihua Guan; Casey Dorr; Rory P Remmel; Arthur J Matas; Roslyn B Mannon; Ajay K Israni; William S Oetting; Pamala A Jacobson
Journal:  Clin Transplant       Date:  2018-10-31       Impact factor: 2.863

3.  Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.

Authors:  John A O'Regan; Mark Canney; Dervla M Connaughton; Patrick O'Kelly; Yvonne Williams; Geraldine Collier; Declan G deFreitas; Conall M O'Seaghdha; Peter J Conlon
Journal:  J Nephrol       Date:  2015-09-15       Impact factor: 3.902

4.  Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

Authors:  David J Taber; Zemin Su; James N Fleming; John W McGillicuddy; Maria A Posadas-Salas; Frank A Treiber; Derek Dubay; Titte R Srinivas; Patrick D Mauldin; William P Moran; Prabhakar K Baliga
Journal:  Transplantation       Date:  2017-12       Impact factor: 4.939

5.  Role of pharmacogenomics in dialysis and transplantation.

Authors:  Kelly Birdwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

6.  Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol.

Authors:  Petra M Goldsmith; Matthew J Bottomley; Okidi Okechukwu; Victoria C Ross; Ryan Ghita; David Wandless; Stuart J Falconer; Stavros Papachristos; Philip Nash; Vitaliy Androshchuk; Marc Clancy
Journal:  BMJ Open       Date:  2017-07-28       Impact factor: 2.692

Review 7.  The Role of Intra-Patient Variability of Tacrolimus Drug Concentrations in Solid Organ Transplantation: A Focus on Liver, Heart, Lung and Pancreas.

Authors:  Gwendal Coste; Florian Lemaitre
Journal:  Pharmaceutics       Date:  2022-02-08       Impact factor: 6.321

8.  A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients.

Authors:  Kim L W Bunthof; Linda Al-Hassany; Gizal Nakshbandi; Dennis A Hesselink; Ron H N van Schaik; Marc A G J Ten Dam; Marije C Baas; Luuk B Hilbrands; Teun van Gelder
Journal:  Clin Transl Sci       Date:  2021-12-15       Impact factor: 4.438

9.  High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation.

Authors:  Cristina Dopazo; Itxarone Bilbao; Sonia García; Concepción Gómez-Gavara; Mireia Caralt; Isabel Campos-Varela; Lluis Castells; Ernest Hidalgo; Francisco Moreso; Bruno Montoro; Ramón Charco
Journal:  Clin Transl Sci       Date:  2022-04-19       Impact factor: 4.438

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.